Correction: This article has been changed to correct the spelling of attorney Wilfred P. Coronato of Hughes Hubbard & Reed’s name.
Pfizer Inc. has won a defense verdict in Massachusetts federal court against allegations that a plaintiff was not adequately warned of the risks of developing pulmonary arterial hypertension from using the Fen-Phen diet-drug duo.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
